Adhesion Receptors as Therapeutic Targets (Preclinical development of c7E3 Fab; a mouse/human chimeric monclonal antibody fragment that inhibits platelet function by blockade of GPIIb/IIIa receptors with observations on the immunogenicity of c7E3 Fab in humans, 1996)
p.